Enjoy a complimentary lunch and vote for your favorite posters as part of the 2024 Johns Hopkins Research Symposium on Engineering in Healthcare, "From the Research Lab to the Market: The Science of T ...

On Monday 20 January 2025 we concluded AI Day 2025 - our Internal Research Symposium in Data Science and AI, and it was a ...

Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Pelareorep combination therapy shows continued meaningful improvement over checkpoint inhibitors alone in anal cancer patients Thomas Heineman, M.D., Ph.D., Chief Medical Officer for Oncolytics ...

Lisata Therapeutics (LSTA) announced preliminary Cohort A data from the ongoing Phase 2 ASCEND trial being conducted at 25 sites across ...

On January 31, NC State's Integrative Sciences Initiative will host the second annual Integrative Symposium of NC State Training Grants. The initiative will bring together six NIH-funded T32 programs ...

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium ...

In pancreatic cancer, pelareorep previously demonstrated a strong efficacy signal when administered with gemcitabine, nab-paclitaxel and atezolizumab. Our new safety data indicate its ability to also ...

The researchers reported these findings in a poster presented at the San Antonio Breast Cancer Symposium 2024. The study included ... as their initial GnRH agonist. “Further research is needed to ...

The symposium will consist of plenary lectures and invited talks, contributed presentations, and poster sessions covering a wide range of topics spanning the research area of nanoscience and ...